CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,502,452 | +72.0% | 39,106 | +3.6% | 0.00% | – |
| Q1 2023 | $873,634 | -84.0% | 37,738 | -81.9% | 0.00% | -100.0% |
| Q4 2022 | $5,463,538 | +42.5% | 208,532 | +6.9% | 0.00% | +100.0% |
| Q3 2022 | $3,835,000 | -36.7% | 195,110 | -43.7% | 0.00% | -50.0% |
| Q2 2022 | $6,063,000 | +1098.2% | 346,654 | +1021.9% | 0.00% | – |
| Q1 2022 | $506,000 | +181.1% | 30,899 | +179.7% | 0.00% | – |
| Q4 2021 | $180,000 | +17.6% | 11,047 | -7.9% | 0.00% | – |
| Q3 2021 | $153,000 | +3.4% | 11,992 | +14.4% | 0.00% | – |
| Q2 2021 | $148,000 | – | 10,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |